TPH
From Proteopedia
| Line 1: | Line 1: | ||
==Tryptophan hydroxylase== | ==Tryptophan hydroxylase== | ||
| - | Tryptophan hydroxylase (TPH) (tryptophan 5-monooxygenase, EC 1.14.16.4) catalyses the reaction between tryptophan, 5,6,7,8-tetrahydrobiopterin ( | + | Tryptophan hydroxylase (TPH) (tryptophan 5-monooxygenase, EC 1.14.16.4) catalyses the reaction between tryptophan, 5,6,7,8-tetrahydrobiopterin (BH<sub>4</sub>) and O<sub>2</sub> to give 5-hydroxytryptophan and 4a-hydroxy-tetrahydrobiopterin (4a-hydroxy-BH<sub>4</sub>. This reaction is the first and rate limiting step in the biosynthesis of serotonin (See scheme). |
| - | Together with phenylalanine hydroxylase (EC 1.14.16.1) and tyrosine hydroxylase (EC 1.14.16.2), TPH form the small enzyme family of aromatic amino acid hydroxylases (AAAH) []. These enzymes all contain iron and use | + | Together with phenylalanine hydroxylase (EC 1.14.16.1) and tyrosine hydroxylase (EC 1.14.16.2), TPH form the small enzyme family of aromatic amino acid hydroxylases (AAAH) []. These enzymes all contain iron and use BH<sub>4</sub> as a co-substrate in the hydroxylation of their respective aromatic amino acids [ , , ]. Additionally all mammalian AAAH form homotetramers and each monomer consists of three domains. These domains are the N-terminal regulatory domain (100-150 residues), the catalytic domain (approximately 315 residues) and the C-terminal tetramerisation domain (approximately 30-40 residues) [ , , , ]. |
==The two isoforms of tryptophan hydroxylase== | ==The two isoforms of tryptophan hydroxylase== | ||
| Line 8: | Line 8: | ||
The two isoforms are expressed in different tissues. TPH2 is mainly expressed in serotonergic neurons of the brain and gut [, , , , ]. TPH1 is expressed in other parts of the body such as the pineal gland [4,27], skin cells [ ], mast cells [1], intestinal mucosa and enterochromafin cells [ ] and in cancer cells [ , ]. The main difference between the two isoforms is that the N-terminal is extended by 46 residues in TPH2 [ ]. | The two isoforms are expressed in different tissues. TPH2 is mainly expressed in serotonergic neurons of the brain and gut [, , , , ]. TPH1 is expressed in other parts of the body such as the pineal gland [4,27], skin cells [ ], mast cells [1], intestinal mucosa and enterochromafin cells [ ] and in cancer cells [ , ]. The main difference between the two isoforms is that the N-terminal is extended by 46 residues in TPH2 [ ]. | ||
| + | '''Two structures are available of the catalytic domain of TPH1.''' | ||
| + | <br/> | ||
| + | The structure '''[[1mlw]]''' is the catalytic domain of human TPH1 with bound dihydrobiopterin.<br/> | ||
| + | The structure '''[[3e2t]]''' is the catalytic domain of ckicken TPH1 with bound tryptophan | ||
| - | This is a placeholder text to help you get started in | ||
| - | placing a Jmol applet on your page. At any time, click | ||
| - | "Show Preview" at the bottom of this page to see how it goes. | ||
| - | |||
| - | Replace the PDB id (use lowercase!) after the STRUCTURE_ and after PDB= to load | ||
| - | and display another structure. | ||
{{STRUCTURE_1mlw | PDB=1mlw | SCENE= }} | {{STRUCTURE_1mlw | PDB=1mlw | SCENE= }} | ||
Revision as of 08:56, 3 April 2009
Tryptophan hydroxylase
Tryptophan hydroxylase (TPH) (tryptophan 5-monooxygenase, EC 1.14.16.4) catalyses the reaction between tryptophan, 5,6,7,8-tetrahydrobiopterin (BH4) and O2 to give 5-hydroxytryptophan and 4a-hydroxy-tetrahydrobiopterin (4a-hydroxy-BH4. This reaction is the first and rate limiting step in the biosynthesis of serotonin (See scheme).
Together with phenylalanine hydroxylase (EC 1.14.16.1) and tyrosine hydroxylase (EC 1.14.16.2), TPH form the small enzyme family of aromatic amino acid hydroxylases (AAAH) []. These enzymes all contain iron and use BH4 as a co-substrate in the hydroxylation of their respective aromatic amino acids [ , , ]. Additionally all mammalian AAAH form homotetramers and each monomer consists of three domains. These domains are the N-terminal regulatory domain (100-150 residues), the catalytic domain (approximately 315 residues) and the C-terminal tetramerisation domain (approximately 30-40 residues) [ , , , ].
The two isoforms of tryptophan hydroxylase
TPH exists in two isoforms called TPH isoform 1 (TPH1) and TPH isoform 2 (TPH2) [ ]. The existence of two isoforms was observed when TPH was purified and characterised from different tissues [ , , , , ]. The gene encoding for rabbit TPH1 was identified in 1987 by Grenett et al.[] and a few years later the human gene for TPH1 was identified on chromosome 11 [ , ]. The gene for isoform 2 was identified in 2003 by Walther et al. and the human gene is located on chromosome 12 []. The two isoforms are expressed in different tissues. TPH2 is mainly expressed in serotonergic neurons of the brain and gut [, , , , ]. TPH1 is expressed in other parts of the body such as the pineal gland [4,27], skin cells [ ], mast cells [1], intestinal mucosa and enterochromafin cells [ ] and in cancer cells [ , ]. The main difference between the two isoforms is that the N-terminal is extended by 46 residues in TPH2 [ ].
Two structures are available of the catalytic domain of TPH1.
The structure 1mlw is the catalytic domain of human TPH1 with bound dihydrobiopterin.
The structure 3e2t is the catalytic domain of ckicken TPH1 with bound tryptophan
